Skip to content
10-Q

Quarterly Report

Boundless Bio, Inc. BOLD

0000950170-24-123291

← back to feed
Filed
Nov 7, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 6, 2024 22.3M sh
Short Term Investments Q3 2024 · Sep 30, 2024 $126.92M
Short Term Investments Q3 2024 · Dec 31, 2023 $97.05M
Stockholders Equity Q3 2024 · Sep 30, 2024 $165.08M
Stockholders Equity Q3 2024 · Dec 31, 2023 −$127.08M
Current Liabilities Q3 2024 · Sep 30, 2024 $10.01M
Current Liabilities Q3 2024 · Dec 31, 2023 $9.36M
Current Assets Q3 2024 · Sep 30, 2024 $170.45M
Current Assets Q3 2024 · Dec 31, 2023 $124.2M
Total Assets Q3 2024 · Sep 30, 2024 $175.09M
Total Assets Q3 2024 · Dec 31, 2023 $129.89M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $23.71M
Cash And Equivalents Q3 2024 · Sep 30, 2023 $20.96M
Shares Diluted Q3 2024 · Sep 30, 2023 1.23M sh
Shares Diluted Q3 2024 · Sep 30, 2023 1.21M sh
Capex Q3 2024 · Sep 30, 2023 $365K
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$35.17M
Eps Diluted Q3 2024 · Sep 30, 2023 −$10.71
Eps Diluted Q3 2024 · Sep 30, 2023 −$30.89
Eps Basic Q3 2024 · Sep 30, 2023 −$10.71
Eps Basic Q3 2024 · Sep 30, 2023 −$30.89
Sga Expense Q3 2024 · Sep 30, 2023 $3.31M
Sga Expense Q3 2024 · Sep 30, 2023 $8.78M
Rd Expense Q3 2024 · Sep 30, 2023 $11.65M
Rd Expense Q3 2024 · Sep 30, 2023 $32.22M
Net Income Q3 2024 · Sep 30, 2023 −$13.17M
Net Income Q3 2024 · Sep 30, 2023 −$37.29M
Operating Income Q3 2024 · Sep 30, 2023 −$14.95M
Operating Income Q3 2024 · Sep 30, 2023 −$41M